Cencora Contract Assets decreased by 5.2% to $1.57B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 21.0%, from $1.30B to $1.57B. Over 5 years (FY 2020 to FY 2025), Contract Assets shows an upward trend with a 3.9% CAGR.
An increase indicates growing service-based revenue streams or complex commercialization contracts, while a decrease suggests the conversion of these assets into billed receivables.
This represents the company's right to consideration in exchange for goods or services that have been transferred to a c...
Common in companies providing value-added services to pharmaceutical manufacturers beyond simple distribution.
other_contract_with_customer_asset_gross_current| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.22B | $1.27B | $1.36B | $1.45B | $1.57B | $1.53B | $1.53B | $1.48B | $1.42B | $1.31B | $1.24B | $1.19B | $1.14B | $1.18B | $1.19B | $1.30B | $1.43B | $1.63B | $1.66B | $1.57B |
| QoQ Change | — | +4.6% | +7.1% | +6.6% | +7.9% | -2.2% | -0.2% | -3.2% | -4.3% | -7.2% | -5.5% | -3.9% | -4.3% | +2.8% | +1.4% | +9.1% | +10.0% | +13.6% | +2.2% | -5.2% |
| YoY Change | — | — | — | — | +28.8% | +20.5% | +12.3% | +2.0% | -9.5% | -14.2% | -18.7% | -19.3% | -19.3% | -10.6% | -4.0% | +8.9% | +25.1% | +38.3% | +39.3% | +21.0% |